Actively Recruiting

Phase Not Applicable
Age: 39Years - 49Years
FEMALE
NCT06522568

Testing a Mammography Decision Intervention in a Rural Setting

Led by Dartmouth-Hitchcock Medical Center · Updated on 2025-09-29

39

Participants Needed

1

Research Sites

34 weeks

Total Duration

On this page

Sponsors

D

Dartmouth-Hitchcock Medical Center

Lead Sponsor

T

Trustees of Dartmouth College

Collaborating Sponsor

AI-Summary

What this Trial Is About

The overall objective of this COBRE pilot project is to enhance the design of a 3-arm cluster randomized trial that will test the efficacy and mechanism of effect of the MyMammogram DA with or without a provider communication intervention. This will be accomplished through two aims: (1) Refine, with community partner input, a clinical trial protocol to optimize engagement among patients and primary care providers (PCPs) practicing in rural settings. In consultation with patients, PCPs, and informatics experts, the study team will refine site selection, randomization, patient and PCP recruitment, and data collection protocols to meet the needs of the rural health care delivery system and participants. The result of this aim will be a modified protocol and intervention strategy that is acceptable to partners. (2) Adapt and test trial and intervention implementation features to achieve protocol acceptance and adherence. The investigators will pilot the adapted three-arm randomized trial protocol in rural primary care settings that compares the MyMammogram DA with or without a risk summary provided to the PCP pre-visit, relative to usual care. Implementing the trial in two phases (n=15 each) will systematically identify barriers and facilitators to trial participation to refine protocols. Participants will receive acceptability surveys and investigators will conduct qualitative interviews with patients and PCPs to understand experiences with trial implementation from multiple perspectives.

CONDITIONS

Official Title

Testing a Mammography Decision Intervention in a Rural Setting

Who Can Participate

Age: 39Years - 49Years
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Female
  • Aged 39 to 49 years
  • Upcoming appointment with a participating primary care provider within 4 weeks
  • English or Spanish-speaking
Not Eligible

You will not qualify if you...

  • Personal history of breast cancer including lobular carcinoma in situ, ductal carcinoma in situ, or atypical hyperplasia
  • Mammogram in the prior 12 months

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Cheshire Medical Center

Keene, New Hampshire, United States, 03431

Actively Recruiting

Loading map...

Research Team

C

Christine M Gunn, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

PREVENTION

Number of Arms

3

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here